Galapagos reported EUR-156367000 in Pre-Tax Profit for its fiscal quarter ending in March of 2025.


Pre Tax Profit Change Date
argenx SE USD 286.9M 84.54M Jun/2025
AstraZeneca USD 3.13B 275M Jun/2025
Biogen USD 744M 432.8M Jun/2025
Genmab DKK 423M 179M Jun/2025
Gilead Sciences USD 2.43B 780M Jun/2025
GlaxoSmithKline GBP 1.89B 221M Jun/2025
GRIFOLS EUR 190.51M 20.03M Jun/2025
Hikma Pharmaceutical USD 144M 144M Jun/2024
Incyte USD 558.01M 323.82M Jun/2025
Merck EUR 829M 127M Jun/2025
Neurocrine Biosciences USD 159.5M 144.8M Jun/2025
Novartis USD 4.53B 124M Jun/2025
Roche Holding CHF 1.78B 2.33B Dec/2024
Sanofi EUR 1.42B 734M Jun/2025
UCB EUR 1.22B 781M Dec/2024
Vertex Pharmaceuticals USD 1.28B 552.6M Jun/2025